Enzi/Kennedy Drug Safety Bill Will Expand FDA’s Oversight Armamentarium
Executive Summary
Drug safety legislation from Senate Health Committee Chairman Michael Enzi (R-Wyo.) will make FDA's enforcement authority more subtle than merely having the ability to pull drugs from the market
You may also be interested in...
Gardasil Use Suggests Need For PDUFA Post-Market Provisions, Senator Says
The use of Merck's human papilloma virus vaccine Gardasil in girls as young as nine years old underscores the need to apply FDA user fee funds to post-marketing surveillance of products, Sen. Barbara Mikulski, D-Md., said during a Senate Health Committee hearing March 14
Gardasil Use Suggests Need For PDUFA Post-Market Provisions, Senator Says
The use of Merck's human papilloma virus vaccine Gardasil in girls as young as nine years old underscores the need to apply FDA user fee funds to post-marketing surveillance of products, Sen. Barbara Mikulski, D-Md., said during a Senate Health Committee hearing March 14
Risk Management Submissions Need To Be Better Organized, FDA Says
Industry submissions of risk management plans are not following FDA's guidance for the organization of the materials, agency officials said during a recent webinar sponsored by the Drug Information Association